About: Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on September 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована у вересні 2013 (uk) مقالة علمية نشرت في سبتمبر 2013 (ar) scientific article published on September 2013 (en)
publication date	wds:Q37162479-C4179D3A-28CF-4FD6-A208-D0507A211E3F
publication date	2013-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37162479-2BF4D476-AF19-4D35-B20D-9B2F9714519D
language of work or name	English
cites work	wds:Q37162479-013F3042-BE5B-4E5F-B044-1DCBCD414C6B wds:Q37162479-063EED6C-D15F-41DE-96F2-F2396938064A wds:Q37162479-111EF625-A713-4D12-82CF-57D42B960FE2 wds:Q37162479-11DA4870-B9DA-4CF8-B495-F5225DCE43CA wds:Q37162479-26CD5626-618D-4FE5-8827-FDB3144F4C78 wds:Q37162479-30434D93-0253-4AC0-9A24-2188EEB38BC3 wds:Q37162479-485B76D9-9F81-4EDF-A9C9-97F624C93390 wds:Q37162479-4A289B13-BE57-4B2C-B283-F415E9D21768 wds:Q37162479-56D9EA61-EC30-47E9-9897-0201750F4163 wds:Q37162479-66AA0E00-8752-4526-8638-4B263E3A72F8 wds:Q37162479-859060F2-C87A-4B3D-A9F4-ABE517A5B5D4 wds:Q37162479-8BA64956-7E24-48DA-B6F4-EB8F568969EF wds:Q37162479-8F33AE97-1873-43C6-B0F0-17A32711E390 wds:Q37162479-926DF59D-1954-44CA-A03D-189B9C74A113 wds:Q37162479-953ACF98-CC1B-4441-8D83-C4A6023B37DE wds:Q37162479-9648B9C1-7AF9-4EC3-845B-32AC4460960A wds:Q37162479-97A729B1-A930-4EE1-B69F-96949B9E0E03 wds:Q37162479-9BA598FE-EC83-427B-9410-1FDBE8129F07 wds:Q37162479-A0D6F99A-21CD-48C5-8387-9909F3FAE5D3 wds:Q37162479-BFFFB34B-EEE7-42E1-BD64-B8F43C90D332 wds:Q37162479-C0AE09CB-B701-4BF0-9432-8319728A5112 wds:Q37162479-C56231F0-A22C-4715-A750-32EF3B79F603 wds:Q37162479-E58CB386-4915-4811-9A8D-2E144DED64DF wds:Q37162479-EB8AF16A-475C-445C-B804-F725F45DC56D wds:Q37162479-F2B197D3-189A-441C-85CE-BB6476631F60 wds:Q37162479-FFB7BD69-9038-48B8-A89D-272F67A6C0DE
cites work	Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection Effect of a Proton Pump Inhibitor or an H2-Receptor Antagonist on Prevention of Bleeding From Ulcer After Endoscopic Submucosal Dissection of Early Gastric Cancer: A Prospective Randomized Controlled Trial Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study Protective effect of rebamipide against ammonia-induced gastric mucosal lesions Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine Effect of rebamipide on quality of peptic ulcer healing in rat. Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study The effects of cure of Helicobacter pylori infection on the signal transduction of gastric epithelial cells
author name string	wds:Q37162479-7B169061-DAF0-4F97-9CDC-6F1B949ECD4C wds:Q37162479-7E7012F2-CCEF-4C5D-AFE8-0CBDEB24F7A8 wds:Q37162479-A343EBE4-5A7F-4E2A-BD93-229410D07ED8 wds:Q37162479-C39A2B1F-D01D-40B2-8F3C-9C83029A91A6 wds:Q37162479-FCE92345-576F-461B-A477-B09A7E166ADB
author name string	Masanori Kawasaki Toshiharu Sakurai Shigenaga Matsui Yutaka Asakuma Masaki Takayama
rdfs:label	Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (en) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (nl) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (ast)
skos:prefLabel	Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (en) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (nl) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (ast)
name	Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (en) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (nl) Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (ast)
author	wds:Q37162479-D2B2F73C-8119-4845-A1DA-BDEA30163A72 wds:Q37162479-FF2D4848-D1CF-4075-8260-84E8E46DC508
author	Masatoshi Kudo Hiroshi Kashida
title	wds:Q37162479-5583AEF4-93BA-4BC0-B347-F47537352CE2
title	Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers (en)
page(s)	wds:Q37162479-77AFB5C9-DEE5-4A74-9FF6-59E4EB0DCBCA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software